Nanoemulsion influenza vaccine
US10525121B2 · kind B2 · utility
1Cited by
12References
56Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2015 |
| Grant date | Jan 7, 2020 |
| Priority date | — |
| Expiry date | Nov 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16271
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for inducing an immune response to influenza in a subject comprising administering a nanoemulsion vaccine composition comprising an influenza immunogen or protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.